Stress and Psoriasis: What the Research Actually Shows

Psoriasis is a chronic, immune-mediated skin condition, and long before dermatology had explained why, people living with it noticed that flare-ups seemed to track stress. Survey data backs up that impression: in patient-reported studies, as many as 69 percent of people with psoriasis identify stress as a trigger for their flares. The lived experience is consistent enough that it has become one of the most repeated pieces of psoriasis advice. What is less widely understood is what the underlying biology actually looks like, and how solid the science behind the stress-flare connection really is.

Psoriasis itself is driven by an overactive immune response, in which T cells trigger inflammation that speeds up skin cell turnover, producing the thickened, scaly plaques characteristic of the condition. Psychological stress is thought to interact with this process through the hypothalamic-pituitary-adrenal (HPA) axis, the same brain-to-adrenal-gland signaling chain that governs cortisol release throughout the body. Research has proposed that stress activates a cascade often described as the CRH-POMC-ACTH-corticosteroid axis, releasing corticotropin-releasing hormone, adrenocorticotropic hormone, and ultimately cortisol, both systemically and within skin tissue itself. According to a 2025 review in Frontiers in Medicine, this signaling is associated with increased levels of pro-inflammatory cytokines and decreased anti-inflammatory ones, along with reduced glucocorticoid receptor function, effects that could plausibly worsen psoriatic inflammation rather than calm it.

One of the more specific findings involves cortisol regulation itself, not just inflammation. A study measuring salivary cortisol in people with plaque psoriasis, published in the Journal of Personalized Medicine, found that patients who described their disease as stress-responsive had lower baseline cortisol levels than patients whose psoriasis was not stress-triggered, suggesting a blunted or dysregulated stress-hormone response in at least a subset of patients. That is a more nuanced picture than simply "stress raises cortisol, which worsens skin" - the relationship may run through an impaired ability to mount a normal cortisol response in the first place.

Here is where the science gets more cautious than the popular narrative. A 2018 systematic review and meta-analysis in the British Journal of Dermatology, pooling 39 studies and more than 32,000 patients, calculated a relative risk of 4.92 for psoriasis flares following stressful life events. But the authors were explicit that the underlying evidence base is weak: most of the studies were retrospective, relied on patient recall, and lacked rigorous controls. Their conclusion was that no convincing evidence currently proves a strong, consistent link between preceding stress and psoriasis exacerbation, even though the association is widely believed by both patients and clinicians. That gap between reported experience and methodologically rigorous proof is worth sitting with rather than glossing over.

What does appear well supported is the bidirectional nature of the relationship: living with visible, chronic psoriasis is itself a significant source of psychological stress, and that stress can in turn make flares more likely or more severe, creating a self-reinforcing cycle. The National Psoriasis Foundation lists stress as one of the most commonly reported psoriasis triggers and recommends stress management as part of a broader care plan, alongside, not instead of, medical treatment.

None of this means stress-reduction techniques are a substitute for dermatologic treatment, and no relaxation practice has been shown to clear psoriasis on its own. But given how consistently patients report the connection, and the biological plausibility supported by HPA-axis and cytokine research, addressing stress alongside standard treatment is a reasonable, low-risk addition to a psoriasis care plan, not a wellness trend layered on top of real medicine.